Related Experiment Video
Updated: Aug 9, 2026

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells
A G Brooks1, F Borrego, P E Posch
1Structural Biology Section, National Institute of Allergy and Infectious Disease, Rockville, MD 20852, USA.
Insights
The CD94/NKG2A receptor specifically binds to HLA-E, but only when HLA-E is associated with a peptide. Peptide binding influences HLA-E stability and recognition by CD94/NKG2A.
Area of Science:
- Immunology
- Molecular Biology
- Cellular Biology
Background:
- CD94/NKG2 receptors on NK and T cells bind to HLA class I molecules.
- Understanding the precise ligand specificity of CD94/NKG2 is crucial for immune response research.
Purpose of the Study:
- To investigate the ligand specificity of CD94/NKG2 receptors, particularly CD94/NKG2A.
- To determine the role of peptide association in HLA-E recognition by CD94/NKG2A.
Main Methods:
- Production of a soluble heterodimeric CD94/NKG2A receptor.
- Direct binding studies using cells expressing defined HLA class I/peptide complexes.
- Functional assays utilizing CD94/NKG2A+ NK cells.
Main Results:
- CD94/NKG2A specifically interacts with HLA-E, dependent on peptide association.
- No interaction was observed between CD94/NKG2A and classical HLA class I molecules.
- Peptides stabilize HLA-E surface expression, and variations affect recognition by CD94/NKG2A.
Conclusions:
- CD94/NKG2A recognition of HLA-E is peptide-controlled at two levels: HLA-E stabilization and ligand formation.
- Peptide sequence is critical for both HLA-E cell surface expression and CD94/NKG2A binding.
Abstract:
The CD94/NKG2 receptors expressed by subpopulations of NK cells and T cells have been implicated as receptors for a broad range of both classical and nonclassical HLA class I molecules. To examine the ligand specificity of CD94/NKG2 proteins, a soluble heterodimeric form of the receptor was produced and used in direct binding studies with cells expressing defined HLA class I/peptide complexes. We confirm that CD94/NKG2A specifically interacts with HLA-E and demonstrate that this interaction is dependent on the association of HLA-E with peptide. Moreover, no interaction between CD94/NKG2A and classical HLA class I molecules was observed, as assayed by direct binding of the soluble receptor or by functional assays using CD94/NKG2A+ NK cells. The role of the peptide associated with HLA-E in the interaction between HLA-E and CD94/NKG2A was also assessed. All class I leader sequence peptides tested bound to HLA-E and were recognized by CD94/NKG2A. However, amino acid variations in class I leader sequences affected the stability of HLA-E. Additionally, not all HLA-E/peptide complexes examined were recognized by CD94/NKG2A. Thus CD94/NKG2A recognition of HLA-E is controlled by peptide at two levels; first, peptide must stabilize HLA-E and promote cell surface expression, and second, the HLA-E/peptide complex must form the ligand for CD94/NKG2A.
More Related Videos
05:24Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
09:32Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021